BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17979211)

  • 1. Structural and ligand-binding properties of serum albumin species interacting with a biomembrane interface.
    Kosa T; Nishi K; Maruyama T; Sakai N; Yonemura N; Watanabe H; Suenaga A; Otagiri M
    J Pharm Sci; 2007 Nov; 96(11):3117-24. PubMed ID: 17979211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand binding at membrane mimetic interfaces. Human serum albumin in reverse micelles.
    Desfosses B; Cittanova N; Urbach W; Waks M
    Eur J Biochem; 1991 Jul; 199(1):79-87. PubMed ID: 1712302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species-dependent stereoselective drug binding to albumin: a circular dichroism study.
    Pistolozzi M; Bertucci C
    Chirality; 2008 Mar; 20(3-4):552-8. PubMed ID: 18172833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subdomain IIIA of dog albumin contains a binding site similar to site II of human albumin.
    Kaneko K; Fukuda H; Chuang VT; Yamasaki K; Kawahara K; Nakayama H; Suenaga A; Maruyama T; Otagiri M
    Drug Metab Dispos; 2008 Jan; 36(1):81-6. PubMed ID: 17925384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A drug release-facilitating mechanism for human serum albumin in reverse micelles: requirement of a structural switch.
    Desfosses B; Nicot C; Waks M
    Biochem Int; 1992 Feb; 26(2):257-64. PubMed ID: 1558538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The location of the high- and low-affinity bilirubin-binding sites on serum albumin: ligand-competition analysis investigated by circular dichroism.
    Goncharova I; Orlov S; Urbanová M
    Biophys Chem; 2013; 180-181():55-65. PubMed ID: 23838624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nonenzymatic glycation and fatty acids on functional properties of human albumin.
    Lautenslager GT; Shearman CW; Hud E; Cohen MP
    Metabolism; 2011 Dec; 60(12):1683-91. PubMed ID: 21632076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding sites of fluorescent probes on human serum albumin.
    Muller N; Lapicque F; Drelon E; Netter P
    J Pharm Pharmacol; 1994 Apr; 46(4):300-4. PubMed ID: 7519671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of drug binding sites on mammalian albumins.
    Panjehshahin MR; Yates MS; Bowmer CJ
    Biochem Pharmacol; 1992 Sep; 44(5):873-9. PubMed ID: 1382424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fluorescence study of human serum albumin binding sites modification by hypochlorite.
    Lissi E; Alicia Biasutti M; Abuin E; León L
    J Photochem Photobiol B; 2009 Feb; 94(2):77-81. PubMed ID: 19036598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural studies of bovine, equine, and leporine serum albumin complexes with naproxen.
    Bujacz A; Zielinski K; Sekula B
    Proteins; 2014 Sep; 82(9):2199-208. PubMed ID: 24753230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species differences of serum albumins: III. Analysis of structural characteristics and ligand binding properties during N-B transitions.
    Kosa T; Maruyama T; Sakai N; Yonemura N; Yahara S; Otagiri M
    Pharm Res; 1998 Apr; 15(4):592-8. PubMed ID: 9587956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative analysis on the binding characteristics of various mammalian albumins towards a multitherapeutic agent, pinostrobin.
    Feroz SR; Sumi RA; Malek SN; Tayyab S
    Exp Anim; 2015; 64(2):101-8. PubMed ID: 25519455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug binding sites on chicken albumin: a comparison to human albumin.
    Rajaian H; Symonds HW; Bowmer CJ
    J Vet Pharmacol Ther; 1997 Dec; 20(6):421-6. PubMed ID: 9430764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of human serum albumin with a novel antidiabetic agent--SU-118.
    Zhong W; Wang Y; Yu JS; Liang Y; Ni K; Tu S
    J Pharm Sci; 2004 Apr; 93(4):1039-46. PubMed ID: 14999739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput solution-based medicinal library screening against human serum albumin.
    Flarakos J; Morand KL; Vouros P
    Anal Chem; 2005 Mar; 77(5):1345-53. PubMed ID: 15732917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (EZ)-Cyclobilirubin formation from bilirubin in complex with serum albumin derived from various species.
    Iwase T; Kusaka T; Itoh S
    J Photochem Photobiol B; 2010 Feb; 98(2):138-43. PubMed ID: 20047841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration-dependent reversible self-oligomerization of serum albumins through intermolecular β-sheet formation.
    Bhattacharya A; Prajapati R; Chatterjee S; Mukherjee TK
    Langmuir; 2014 Dec; 30(49):14894-904. PubMed ID: 25409497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of serotonin in protein and membrane mimetic environments: a spectroscopic study.
    Sengupta B; Chaudhuri S; Banerjee A; Sengupta PK
    Chem Biodivers; 2004 Jun; 1(6):868-77. PubMed ID: 17191887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species differences of serum albumins: I. Drug binding sites.
    Kosa T; Maruyama T; Otagiri M
    Pharm Res; 1997 Nov; 14(11):1607-12. PubMed ID: 9434282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.